Literature DB >> 11844219

The mast cell in wound healing.

C Noli1, A Miolo.   

Abstract

This review describes the role of the mast cell in the pathobiology of skin healing. After illustrating its main morphofunctional characteristics, with special reference to the dog and cat, we consider the involvement of the mast cell in the various phases of skin repair. With the aid of a wide array of newly formed or preformed mediators released by degranulation, the activated mast cell controls the key events of the healing phases: triggering and modulation of the inflammatory stage, proliferation of connective cellular elements and final remodelling of the newly formed connective tissue matrix. The importance of the mast cell in regulating healing processes is also demonstrated by the fact that a surplus or deficit of degranulated biological mediators causes impaired repair, with the formation of exuberant granulation tissue (e.g. keloids and hypertrophic scars), delayed closure (dehiscence) and chronicity of the inflammatory stage.

Entities:  

Mesh:

Year:  2001        PMID: 11844219     DOI: 10.1046/j.0959-4493.2001.00272.x

Source DB:  PubMed          Journal:  Vet Dermatol        ISSN: 0959-4493            Impact factor:   1.589


  61 in total

1.  The heparin-binding domain of HB-EGF mediates localization to sites of cell-cell contact and prevents HB-EGF proteolytic release.

Authors:  Robin N Prince; Eric R Schreiter; Peng Zou; H Steven Wiley; Alice Y Ting; Richard T Lee; Douglas A Lauffenburger
Journal:  J Cell Sci       Date:  2010-06-08       Impact factor: 5.285

Review 2.  What do we mean by the term "inflammation"? A contemporary basic science update for sports medicine.

Authors:  A Scott; K M Khan; C R Roberts; J L Cook; V Duronio
Journal:  Br J Sports Med       Date:  2004-06       Impact factor: 13.800

3.  The role of mast cells in the early stages of wound healing.

Authors:  Chiara Noli; Alda Miolo
Journal:  Int Wound J       Date:  2010-12       Impact factor: 3.315

Review 4.  Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies.

Authors:  Gerd G Gauglitz; Hans C Korting; Tatiana Pavicic; Thomas Ruzicka; Marc G Jeschke
Journal:  Mol Med       Date:  2010-10-05       Impact factor: 6.354

5.  An antimicrobial peptide with angiogenic properties, AG-30/5C, activates human mast cells through the MAPK and NF-κB pathways.

Authors:  Kazo Kanazawa; Ko Okumura; Hideoki Ogawa; François Niyonsaba
Journal:  Immunol Res       Date:  2016-04       Impact factor: 2.829

Review 6.  Microgravity and the implications for wound healing.

Authors:  Ramin Mostofizadeh Farahani; Luisa A DiPietro
Journal:  Int Wound J       Date:  2008-09-19       Impact factor: 3.315

Review 7.  Wound repair at a glance.

Authors:  Tanya J Shaw; Paul Martin
Journal:  J Cell Sci       Date:  2009-09-15       Impact factor: 5.285

8.  The role of mast cells in non-ablative laser resurfacing with 1,320 nm neodymium:yttrium-aluminium-garnet laser.

Authors:  Yingbin Shang; Zhan Wang; Ying Pang; Peng Xi; Qiushi Ren
Journal:  Lasers Med Sci       Date:  2009-06-30       Impact factor: 3.161

9.  Structural changes in the skin of hairless mice following exposure to sulfur mustard correlate with inflammation and DNA damage.

Authors:  Laurie B Joseph; Donald R Gerecke; Diane E Heck; Adrienne T Black; Patrick J Sinko; Jessica A Cervelli; Robert P Casillas; Michael C Babin; Debra L Laskin; Jeffrey D Laskin
Journal:  Exp Mol Pathol       Date:  2011-06-13       Impact factor: 3.362

10.  Mast cell hyperplasia in the skin of Dsg4-deficient hypotrichosis mice, which are long-living mutants of lupus-prone mice.

Authors:  Ming-Cai Zhang; Hiroshi Furukawa; Kazuhiro Tokunaka; Kan Saiga; Fumiko Date; Yuji Owada; Masato Nose; Masao Ono
Journal:  Immunogenetics       Date:  2008-08-02       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.